Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-473-6 | CAS number: 121-47-1
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a GLP compliant study according to OECD guideline 429 3 -aminobenzenesulfonic acid formulated in dimethylsulfoxide was assessed for its possible skin sensitising potential (Harlan CCR 2012). For this purpose a local lymph node assay was performed using test item concentrations of 0.05, 0.1 and 0.25% (w/w). The highest concentration tested was the highest concentration that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation as confirmed by three pre-experiments. The animals did not show any signs of systemic toxicity during the course of the study and no cases of mortality were observed. On day 2 a very slight erythema of the ears was observed in the animals treated with 0.25% of the test item (score: 1). On day 4, a very slight erythema of the ears was observed in all treatment groups (score: 1). Moreover, a statistically significant increase in ear weights was observed in the animals treated with 0.25% of the test item, indicating an irritation potential of the test item. In this study Stimulation Indices (S.I.) of 0.87, 0.97 and 0.78 were determined with the test item at concentrations of 0.05, 0.1 and 0.25% (w/w) in dimethylsulfoxide, respectively. A dose response was not observed. 3 -Aminobenzenesulfonic acid was not a skin sensitiser under the test conditions of this study.
Migrated from Short description of key information:
3-Aminobenzenesulfonic acid was not a skin sensitiser under the test conditions of this LLNA study in mice.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the available data, the substance does not need to be classified for skin sensitisation according to Directive 67/548/EEC and according to the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
